3 months ago
LLY
AnalystsRajesh KumarRajesh Kumar's Stock Forecasts
AnalystsRajesh Kumar
Analyst Ranking
Top 34%
#1796 out of 5312 analysts
Average Return
+3.88%
Win Rate
43%10 out of 23
Risk vs Reward
Poor
Good
Rajesh Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +111.01% | $449.46 | $948.40 | 2023-07-13 - 2024-07-12 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +106.12% | $10.13 | $20.88 | 2023-12-18 - 2024-12-17 | Strong Buy |
Bristol Myers Squibb CoBMY | +17.63% | $61.94 | $51.02 | 2023-07-13 - 2023-10-27 | Sell |
Eli Lilly & CoLLY | +16.31% | $877.29 | $734.17 | 2025-04-28 - 2025-08-27 | Sell |
Unitedhealth Group IncUNH | +13.52% | $526.55 | $455.38 | 2023-12-18 - 2024-04-04 | Sell |
Rajesh Kumar Analyst Color
Get additional color on Rajesh Kumar's coverage of popular stocks
9 months ago
NVO
10 months ago
LLY
a year ago
LLY
a year ago
KDP
3 years ago
PFE
3 years ago
LLY
Rajesh Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Danaher CorpDHR | 2 | Strong Buy | $230.00 | +17.23% | Maintains | a month ago |
Eli Lilly & CoLLY | 4 | Sell | $850.00 | -29.64% | Downgrades | 3 months ago |
Pfizer IncPFE | 2 | Strong Buy | $32.00 | +31.74% | Maintains | 3 months ago |
Biogen IncBIIB | 2 | Sell | $150.00 | -30.57% | Maintains | 3 months ago |
Bristol Myers Squibb CoBMY | 3 | Hold | $60.00 | +4.31% | Maintains | 3 months ago |
Abbvie IncABBV | 4 | Strong Buy | $265.00 | +4.60% | Upgrades | 7 months ago |
Iqvia Holdings IncIQV | 2 | Strong Buy | $235.00 | +22.95% | Upgrades | 9 months ago |
Novo Nordisk A SNVO | 1 | Strong Buy | $70.00 | +45.62% | Upgrades | 9 months ago |
Keurig Dr Pepper IncKDP | 1 | Strong Buy | $42.00 | N/A | Upgrades | a year ago |
Thermo Fisher Scientific IncTMO | 3 | Strong Buy | $670.00 | N/A | Maintains | 2 years ago |
Unitedhealth Group IncUNH | 2 | Hold | $460.00 | N/A | Upgrades | 2 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 3 years ago |
Moderna IncMRNA | 1 | Sell | $97.00 | N/A | Initiates Coverage On | 3 years ago |
Biontech SeBNTX | 1 | Strong Buy | $124.00 | N/A | Initiates Coverage On | 3 years ago |
Merck & Co IncMRK | 1 | Hold | $123.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.